McKesson Corporation
As of Oct 22, 2026, McKesson is in Stage 2, the uptrend phase, now in week 7 (since Sep 3, 2026). It closed at $1,012.34, 1.7% below its 52-week high and above its 200-day average, which is rising.
McKesson Corporation provides healthcare services in the United States and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 3 in Medical Distribution · #1 of 272 in Health Care
Is MCK early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
MCK among Medical Distribution4th of 11 by relative strength
All 11 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | FOCL | Stage 4 · wk 1 | 92 | −12.4% |
| 2 | CAH | Stage 2 · wk 1 | 90 | +15.8% |
| 3 | HSIC | Stage 3 · wk 1 | 79 | +1.1% |
| 4 | MCK | Stage 2 · wk 7 | 76 | +15.0% |
| 5 | COR | Stage 2 · wk 4 | 58 | +8.4% |
| 6 | AHG | Stage 4 · wk 16 | 36 | +58.4% |
| 7 | YI | Stage 4 · wk 16 | 32 | −17.3% |
| 8 | COSM | Stage 1 · wk 7 | 13 | −37.8% |
McKesson: quick answers
What stage is McKesson in?
As of Oct 22, 2026, McKesson (MCK) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 3, 2026 and is in week 7. What the four stages mean
Is McKesson in an uptrend?
Yes. McKesson is in a Stage 2 uptrend. It trades 18.2% above its 200-day average, which is rising.
How far is McKesson from its 52-week high?
McKesson closed at $1,012.34 on Oct 22, 2026, 1.7% below its 52-week high of $1,030.12. Its 52-week low is $723.60.
How has McKesson performed over the past year?
As of Oct 22, 2026, McKesson is up 29.1% over the past year and up 23.3% so far in 2026.
Which sector and industry is McKesson in?
McKesson is in the Medical Distribution industry, part of the Health Care sector.
About this companyHealth Care· Medical Distribution
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.